Last reviewed · How we verify
NCT04888260
Plasma Mannose Associated Parameter Levels in Nondiabetic Coronary Artery Disease
trial testing Laboratory parameter levels in blood samples in Coronary Artery Disease in 240 participants. Completed in 15 May 2020.
10 May 2020
Quick facts
| Lead sponsor | Kafkas University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 240 |
| Start date | 10 January 2018 |
| Primary completion | 10 May 2020 |
| Estimated completion | 15 May 2020 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Laboratory parameter levels in blood samples
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Hyperlipidemias — all drugs for Hyperlipidemias →
Sponsor
Kafkas University
Who can join
Adults 18 to 100, any sex, with Coronary Artery Disease or Hyperlipidemias. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aims: Nondiabetic patients have been studied to determine whether modest elevations in plasma mannose levels may be associated with a greater incidence of coronary artery disease (CAD). Methods: The plasma mannose, lipids (triglyceride, LDL, HDL, LDL, VLDL) and LDH levels were successfully will be evaluated with respect to subsequent coronary artery disease using records 120 nondiabetic patients and 120 healthy volunteers. CAD was identified from myocardial infarction and new diagnoses of angina. The associations between mannose levels and serum lipid parameters will be investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04888260
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Kafkas University trials
Trials by the same sponsor.
- NCT07296757 — The Effect of Origami Activities on Comfort Level and Quality of Life · NA · enrolling by invitation
- NCT06807047 — Effect of the EpiSchool-M App on Teachers' Epilepsy Knowledge, Attitudes, and Self-Management · NA · completed
- NCT06645457 — The Effect of Stress Ball and 4-7-8 Breathing Technique on Fear, Anxiety and Physiological Parameters · NA · completed
- NCT06675773 — The Effect of Conscious Awareness Development Psychoeducation Program Prepared for Caregivers · NA · not yet recruiting
- NCT06749067 — Effect Of Awareness and Occupatıonal Practıces On Menopausal Women's Psychologıcal Wellbeıng And Menopausal Symptoms · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04888260 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kafkas University
- Last refreshed: 17 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04888260.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing